Advances in the biology of oral cancer

Oral Oncology

Volumn 43, Issue 6, 2007, Pages 523-534

  Tsantoulis, P K ^a   Kastrinakis, N G ^a   Tourvas, A D ^a   Laskaris, G ^a   Gorgoulis, V G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

EBV; HPV; Oncogenes; Oral cancer; Review; Tumor suppressor genes

Indexed keywords

COLLAGENASE 3; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GELATINASE A; GELATINASE B; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; NITROSAMINE; OXYGEN RADICAL; PROTEIN P107; PROTEIN P130; PROTEIN P53; RAS PROTEIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRASTUZUMAB; VASCULOTROPIN RECEPTOR;

ALCOHOL CONSUMPTION; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CHROMOSOME ABERRATION; EPSTEIN BARR VIRUS; GENETIC PREDISPOSITION; HEPATITIS C VIRUS; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKOPLAKIA; LICHEN PLANUS; MALIGNANT TRANSFORMATION; MOUTH CANCER; ONCOGENE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SMOKELESS TOBACCO; SMOKING; SYSTEMATIC REVIEW; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS INFECTION; WART VIRUS;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; MOUTH NEOPLASMS; RISK FACTORS;

EID: 34249844797     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.11.010     Document Type: Review

References (203)

1. Shah J.P., Johnson N.W., and Batsakis J.G. Oral cancer (2003), Taylor & Francis
2. Parkin D.M., Läärä E., and Muir C.S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41 2 (1988) 184-197
3. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005. CA Cancer J Clin 55 1 (2005) 10-30
4. Black R.J., Bray F., Ferlay J., and Parkin D.M. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 33 7 (1997) 1075-1107
5. Warnakulasuriya S., Sutherland G., and Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol 41 3 (2005) 244-260
6. Ogden G.R. Alcohol and oral cancer. Alcohol 35 3 (2005) 169-173
7. Nair U., Bartsch H., and Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 19 4 (2004) 251-262
8. Gupta P.C., and Ray C.S. Smokeless tobacco and health in India and South Asia. Respirology 8 4 (2003) 419-431
9. Goldstein A.M., Blot W.J., Greenberg R.S., Schoenberg J.B., Austin D.F., Preston-Martin S., et al. Familial risk in oral and pharyngeal cancer. Eur J Cancer B Oral Oncol 30B 5 (1994) 319-322
10. Brown L.M., Gridley G., Diehl S.R., Winn D.M., Harty L.C., Otero E.B., et al. Family cancer history and susceptibility to oral carcinoma in Puerto Rico. Cancer 92 8 (2001) 2102-2108
11. Copper M.P., Jovanovic A., Nauta J.J., Braakhuis B.J., de Vries N., van der Waal I., et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 121 2 (1995) 157-160
12. Foulkes W.D., Brunet J.S., Sieh W., Black M.J., Shenouda G., and Narod S.A. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ 313 7059 (1996) 716-721
13. Bongers V., Braakhuis B.J., Tobi H., Lubsen H., and Snow G.B. The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer. Cancer Epidemiol Biomarkers Prev 5 8 (1996) 595-598
14. Ankathil R., Mathew A., Joseph F., and Nair M.K. Is oral cancer susceptibility inherited? Report of five oral cancer families. Eur J Cancer B Oral Oncol 32B 1 (1996) 63-67
15. Sato M., Sato T., Izumo T., and Amagasa T. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 20 10 (1999) 1927-1931
16. Sreelekha T.T., Ramadas K., Pandey M., Thomas G., Nalinakumari K.R., and Pillai M.R. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 37 7 (2001) 593-598
17. González M.V., Alvarez V., Pello M.F., Menéndez M.J., Suárez C., and Coto E. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J Clin Pathol 51 4 (1998) 294-298
18. Harty L.C., Caporaso N.E., Hayes R.B., Winn D.M., Bravo-Otero E., Blot W.J., et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst 89 22 (1997) 1698-1705
19. Sturgis E.M., Dahlstrom K.R., Guan Y., Eicher S.A., Strom S.S., Spitz M.R., et al. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. Cancer Epidemiol Biomarkers Prev 10 3 (2001) 273-275
20. Wang D., Ritchie J.M., Smith E.M., Zhang Z., Turek L.P., and Haugen T.H. Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev 14 3 (2005) 626-632
21. Brennan P., Lewis S., Hashibe M., Bell D.A., Boffetta P., Bouchardy C., et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol 159 1 (2004) 1-16
22. Zheng Y., Shen H., Sturgis E.M., Wang L.E., Eicher S.A., Strom S.S., et al. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis 22 8 (2001) 1195-1199
23. Huang M., Spitz M.R., Gu J., Lee J.J., Lin J., Lippman S.M., et al. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis (2006)
24. Holley S.L., Matthias C., Jahnke V., Fryer A.A., Strange R.C., and Hoban P.R. Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral Oncol 41 2 (2005) 156-160
25. Beer K.T., Greiner R.H., Aebersold D.M., and Zbären P. Carcinoma of the oropharynx: local failure as the decisive parameter for distant metastases and survival. Strahlenther Onkol 176 1 (2000) 16-21
26. Lacy P.D., Spitznagel E.L., and Piccirillo J.F. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma. Cancer 86 8 (1999) 1387-1395
27. Matsuura K., Hirokawa Y., Fujita M., Akagi Y., and Ito K. Treatment results of stage I and II oral tongue cancer with interstitial brachytherapy: maximum tumor thickness is prognostic of nodal metastasis. Int J Radiat Oncol Biol Phys 40 3 (1998) 535-539
28. Bundgaard T., Bentzen S.M., Wildt J., Sørensen F.B., Søgaard H., and Nielsen J.E. Histopathologic, stereologic, epidemiologic, and clinical parameters in the prognostic evaluation of squamous cell carcinoma of the oral cavity. Head Neck 18 2 (1996) 142-152
29. Harris L., Sessions R., and Hong W. Head and neck cancer: a multidisciplinary approach (1998), Lippincott-Raven, Philadelphia
30. Reichard K.W., Joseph K.T., Cohen M., and Greager J.A. Squamous cell carcinoma of the tongue: experience with 86 consecutive cases. J Surg Oncol 54 4 (1993) 239-242
31. Hill B.T., and Price L.A. Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rate. Am J Clin Oncol 17 1 (1994) 1-5
32. Hanson W.G., and Ferguson P.J. Differential methotrexate toxicity between two human oral squamous carcinoma cell lines. J Otolaryngol 22 3 (1993) 143-147
33. Warnakulasuriya K.A., and Johnson N.W. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 25 3 (1996) 97-103
34. Diniz-Freitas M., García-García A., Crespo-Abelleira A., Martins-Carneiro J.L., and Gándara-Rey J.M. Applications of exfoliative cytology in the diagnosis of oral cancer. Med Oral 9 4 (2004) 355-361
35. Li Y., John M.A.R.S., Zhou X., Kim Y., Sinha U., Jordan R.C.K., et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10 24 (2004) 8442-8450
36. Westra W.H., and Califano J. Toward early oral cancer detection using gene expression profiling of saliva: a thoroughfare or dead end?. Clin Cancer Res 10 24 (2004) 8130-8131
37. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 5 (1990) 759-767
38. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
39. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 11 (1996) 2488-2492
40. Neville B.W., and Day T.A. Oral cancer and precancerous lesions. CA Cancer J Clin 52 4 (2002) 195-215
41. Dissemond J. Oral lichen planus: an overview. J Dermatolog Treat 15 3 (2004) 136-140
42. Reichart P.A., and Philipsen H.P. Oral erythroplakia-a review. Oral Oncol 41 6 (2005) 551-561
43. Waldron C.A., and Shafer W.G. Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias. Cancer 36 4 (1975) 1386-1392
44. Einhorn J., and Wersall J. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer 20 12 (1967) 2189-2193
45. Bánóczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg 5 1 (1977) 69-75
46. Silverman S., Gorsky M., and Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53 3 (1984) 563-568
47. Lozada-Nur F., and Miranda C. Oral lichen planus: epidemiology, clinical characteristics, and associated diseases. Semin Cutan Med Surg 16 4 (1997) 273-277
48. Mignogna M.D., Muzio L.L., Russo L.L., Fedele S., Ruoppo E., and Bucci E. Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience. Oral Oncol 37 3 (2001) 262-267
49. Sudbø J. Novel management of oral cancer: a paradigm of predictive oncology. Clin Med Res 2 4 (2004) 233-242
50. Slaughter D.P., Southwick H.W., and Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6 5 (1953) 963-968
51. Braakhuis B.J.M., Tabor M.P., Kummer J.A., Leemans C.R., and Brakenhoff R.H. A genetic explanation of slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63 8 (2003) 1727-1730
52. Braakhuis B.J.M., Leemans C.R., and Brakenhoff R.H. A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 33 6 (2004) 317-322
53. Tabor M.P., Brakenhoff R.H., Ruijter-Schippers H.J., Wal J.E.V.D., Snow G.B., Leemans C.R., et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 161 3 (2002) 1051-1060
54. Soni S., Kaur J., Kumar A., Chakravarti N., Mathur M., Bahadur S., et al. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology 68 4-6 (2005) 314-325
55. Araki D., Uzawa K., Watanabe T., Shiiba M., Miyakawa A., Yokoe H., et al. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity. Int J Oncol 20 2 (2002) 355-360
56. Rupa D.S., and Eastmond D.A. Chromosomal alterations affecting the 1cen-1q12 region in buccal mucosal cells of betel quid chewers detected using multicolor fluorescence in situ hybridization. Carcinogenesis 18 12 (1997) 2347-2351
57. Yamamoto N., Mizoe etsu J., Numasawa H., Tsujii H., Shibahara T., and Noma H. Allelic loss on chromosomes 2q, 3p and 21q: possibly a poor prognostic factor in oral squamous cell carcinoma. Oral Oncol 39 8 (2003) 796-805
58. Yamamoto N., Mizoe etsu J., Numasawa H., Yokoe H., Uzawa K., Shibahara T., et al. Allelic loss of chromosome 2 in human oral squamous cell carcinoma: correlation with lymph node metastasis. Oral Oncol 39 1 (2003) 64-68
59. Numasawa H., Yamamoto N., Katakura A., and Shibahara T. Loss of heterozygosity and microsatellite instability on chromosome 2q in human oral squamous cell carcinoma. Bull Tokyo Dent Coll 46 1-2 (2005) 17-25
60. Wu C.L., Sloan P., Read A.P., Harris R., and Thakker N. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res 54 24 (1994) 6484-6488
61. Ishwad C.S., Ferrell R.E., Rossie K.N., Appel B.N., Johnson J.T., Myers E.N., et al. Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer. Int J Cancer 69 1 (1996) 1-4
62. Partridge M., Kiguwa S., and Langdon J.D. Frequent deletion of chromosome 3p in oral squamous cell carcinoma. Eur J Cancer B Oral Oncol 30B 4 (1994) 248-251
63. Partridge M., Emilion G., and Langdon J.D. LOH at 3p correlates with a poor survival in oral squamous cell carcinoma. Br J Cancer 73 3 (1996) 366-371
64. Wolff E., Girod S., Liehr T., Vorderwülbecke U., Ries J., Steininger H., et al. Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation. Oral Oncol 34 3 (1998) 186-190
65. Okafuji M., Ita M., Hayatsu Y., Shinozaki F., Oga A., and Sasaki K. Identification of genetic aberrations in cell lines from oral squamous cell carcinomas by comparative genomic hybridization. J Oral Pathol Med 28 6 (1999) 241-245
66. Oga A., Kong G., Tae K., Lee Y., and Sasaki K. Comparative genomic hybridization analysis reveals 3q gain resulting in genetic alteration in 3q in advanced oral squamous cell carcinoma. Cancer Genet Cytogenet 127 1 (2001) 24-29
67. Rosin M.P., Cheng X., Poh C., Lam W.L., Huang Y., Lovas J., et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 6 2 (2000) 357-362
68. Pershouse M.A., El-Naggar A.K., Hurr K., Lin H., Yung W.K., and Steck P.A. Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene 14 3 (1997) 369-373
69. Jiang W.W., Fujii H., Shirai T., Mega H., and Takagi M. Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity. Cancer 92 9 (2001) 2349-2356
70. Wang X.L., Uzawa K., Imai F.L., and Tanzawa H. Localization of a novel tumor suppressor gene associated with human oral cancer on chromosome 4q25. Oncogene 18 3 (1999) 823-825
71. Weber R.G., Scheer M., Born I.A., Joos S., Cobbers J.M., Hofele C., et al. Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. Am J Pathol 153 1 (1998) 295-303
72. Okafuji M., Ita M., Oga A., Hayatsu Y., Matsuo A., Shinzato Y., et al. The relationship of genetic aberrations detected by comparative genomic hybridization to DNA ploidy and tumor size in human oral squamous cell carcinomas. J Oral Pathol Med 29 5 (2000) 226-231
73. Mancini U.M., Estécio M.R.H., Góis J.F.F., Fukuyama E.E., Valentim P.J., Cury P.M., et al. The chromosome 5q21 band minisatellite and head and neck cancer. Cancer Genet Cytogenet 147 1 (2003) 87-88
74. Mao E.J., Schwartz S.M., Daling J.R., and Beckmann A.M. Loss of heterozygosity at 5q21-22 (adenomatous polyposis coli gene region) in oral squamous cell carcinoma is common and correlated with advanced disease. J Oral Pathol Med 27 7 (1998) 297-302
75. Queimado L., Reis A., Fonseca I., Martins C., Lovett M., Soares J., et al. A refined localization of two deleted regions in chromosome 6q associated with salivary gland carcinomas. Oncogene 16 1 (1998) 83-88
76. Garnis C., Campbell J., Zhang L., Rosin M.P., and Lam W.L. OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol 40 5 (2004) 511-519
77. Chen Y.J., Lin S.C., Kao T., Chang C.S., Hong P.S., Shieh T.M., et al. Genome-wide profiling of oral squamous cell carcinoma. J Pathol 204 3 (2004) 326-332
78. Steinhart H., Bohlender J., Iro H., Jung V., Constantinidis J., Gebhart E., et al. DNA amplification on chromosome 7q in squamous cell carcinoma of the tongue. Int J Oncol 19 4 (2001) 851-855
79. Zenklusen J.C., Thompson J.C., Klein-Szanto A.J., and Conti C.J. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res 55 6 (1995) 1347-1350
80. Wang X.L., Uzawa K., Miyakawa A., Shiiba M., Watanabe T., Sato T., et al. Localization of a tumour-suppressor gene associated with human oral cancer on 7q31.1. Int J Cancer 75 5 (1998) 671-674
81. Sunwoo J.B., Holt M.S., Radford D.M., Deeker C., and Scholnick S.B. Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer. Genes Chromosomes Cancer 16 3 (1996) 164-169
82. Wu C.L., Roz L., Sloan P., Read A.P., Holland S., Porter S., et al. Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes Cancer 20 4 (1997) 347-353
83. Sunwoo J.B., Sun P.C., Gupta V.K., Schmidt A.P., El-Mofty S., and Scholnick S.B. Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p. Oncogene 18 16 (1999) 2651-2655
84. El-Naggar A.K., Coombes M.M., Batsakis J.G., Hong W.K., Goepfert H., and Kagan J. Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene 16 23 (1998) 2983-2987
85. Ishwad C.S., Shuster M., Bockmühl U., Thakker N., Shah P., Toomes C., et al. Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer. Int J Cancer 80 1 (1999) 25-31
86. Garnis C., Coe B.P., Ishkanian A., Zhang L., Rosin M.P., and Lam W.L. Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer. Genes Chromosomes Cancer 39 1 (2004) 93-98
87. van der Riet P., Nawroz H., Hruban R.H., Corio R., Tokino K., Koch W., et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54 5 (1994) 1156-1158
88. Yamashita Y., Miyakawa A., Mochida Y., Aisaki K., Yama M., Shiiba M., et al. Genetic aberration on chromosome 10 in human oral squamous cell carcinoma. Int J Oncol 20 3 (2002) 595-598
89. Zhou X., Jordan R.C.K., Li Y., Huang B.L., and Wong D.T.W. Frequent allelic imbalances at 8p and 11q22 in oral and oropharyngeal epithelial dysplastic lesions. Cancer Genet Cytogenet 161 1 (2005) 86-89
90. Shuster M.I., Han L., Beau M.M.L., Davis E., Sawicki M., Lese C.M., et al. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer 28 2 (2000) 153-163
91. Huang Q., Yu G.P., McCormick S.A., Mo J., Datta B., Mahimkar M., et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 34 2 (2002) 224-233
92. Ogawara K., Miyakawa A., Shiba M., Uzawa K., Watanabe T., Wang X.L., et al. Allelic loss of chromosome 13q14.3 in human oral cancer: correlation with lymph node metastasis. Int J Cancer 79 4 (1998) 312-317
93. Gebhart E., Liehr T., Wolff E., Ries J., Fiedler W., Steininger H., et al. Pattern of genomic imbalances in oral squamous cell carcinomas with and without an increased copy number of 11q13. Int J Oncol 12 5 (1998) 1151-1155
94. Largey J.S., Meltzer S.J., Yin J., Norris K., Sauk J.J., and Archibald D.W. Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction. Cancer 71 6 (1993) 1933-1937
95. Huang M.F., Chang Y.C., Liao P.S., Huang T.H., Tsay C.H., and Chou M.Y. Loss of heterozygosity of p53 gene of oral cancer detected by exfoliative cytology. Oral Oncol 35 3 (1999) 296-301
96. Lin S.C., Chen Y.J., Kao S.Y., Hsu M.T., Lin C.H., Yang S.C., et al. Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. Oral Oncol 38 3 (2002) 266-273
97. Bockmühl U., Wolf G., Schmidt S., Schwendel A., Jahnke V., Dietel M., et al. Genomic alterations associated with malignancy in head and neck cancer. Head Neck 20 2 (1998) 145-151
98. Imai F.L., Uzawa K., Miyakawa A., Shiiba M., and Tanzawa H. A detailed deletion map of chromosome 20 in human oral squamous cell carcinoma. Int J Mol Med 7 1 (2001) 43-47
99. Chen L., Wong M.P., Cheung L.K., Samaranayake L.P., Baum L., and Samman N. Frequent allelic loss of 21q11.1 approximately q21.1 region in advanced stage oral squamous cell carcinoma. Cancer Genet Cytogenet 159 1 (2005) 37-43
100. Reis P.P., Rogatto S.R., Kowalski L.P., Nishimoto I.N., Montovani J.C., Corpus G., et al. Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer. Oncogene 21 42 (2002) 6480-6487
101. Miyakawa A., Wang X.L., Nakanishi H., Imai F.L., Shiiba M., Miya T., et al. Allelic loss on chromosome 22 in oral cancer: possibility of the existence of a tumor suppressor gene on 22q13. Int J Oncol 13 4 (1998) 705-709
102. el Naggar A.K., Hurr K., Batsakis J.G., Luna M.A., Goepfert H., and Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res 55 12 (1995) 2656-2659
103. Partridge M., Emilion G., Pateromichelakis S., A'Hern R., Lee G., Phillips E., et al. The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer. Br J Cancer 79 11-12 (1999) 1821-1827
104. Patmore H.S., Cawkwell L., Stafford N.D., and Greenman J. Unraveling the chromosomal aberrations of head and neck squamous cell carcinoma: a review. Ann Surg Oncol 12 10 (2005) 831-842
105. Normanno N., Luca A.D., Bianco C., Strizzi L., Mancino M., Maiello M.R., et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366 1 (2006) 2-16
106. Ishitoya J., Toriyama M., Oguchi N., Kitamura K., Ohshima M., Asano K., et al. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 59 4 (1989) 559-562
107. Nagatsuka H., Ishiwari Y., Tsujigiwa H., Nakano K., and Nagai N. Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions. Oral Oncol 37 7 (2001) 599-604
108. Chen I.H., Chang J.T., Liao C.T., Wang H.M., Hsieh L.L., and Cheng A.J. Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer 89 4 (2003) 681-686
109. Shiraki M., Odajima T., Ikeda T., Sasaki A., Satoh M., Yamaguchi A., et al. Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. Mod Pathol 18 11 (2005) 1482-1489
110. Shintani S., Li C., Mihara M., Yano J., Terakado N., Nakashiro ichi K., et al. Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines. Oral Oncol 40 1 (2004) 43-51
111. Shintani S., Li C., Mihara M., Nakashiro ichi K., and Hamakawa H. Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells. Cancer Lett 201 2 (2003) 149-155
112. Cohen E.E.W., Rosen F., Stadler W.M., Recant W., Stenson K., Huo D., et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 21 10 (2003) 1980-1987
113. Kirby A.M., A'Hern R.P., D'Ambrosio C., Tanay M., Syrigos K.N., Rogers S.J., et al. Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancer. Br J Cancer 94 5 (2006) 631-636
114. Xia W., Lau Y.K., Zhang H.Z., Liu A.R., Li L., Kiyokawa N., et al. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res 3 1 (1997) 3-9
115. Werkmeister R., Brandt B., and Joos U. Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity. Br J Oral Maxillofac Surg 37 6 (1999) 477-480
116. Werkmeister R., Brandt B., and Joos U. Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas. Oral Oncol 36 1 (2000) 100-105
117. Caulin C., Nguyen T., Longley M.A., Zhou Z., Wang X.J., and Roop D.R. Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res 64 15 (2004) 5054-5058
118. Xu J., Gimenez-Conti I.B., Cunningham J.E., Collet A.M., Luna M.A., Lanfranchi H.E., et al. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 83 2 (1998) 204-212
119. Kiaris H., Spandidos D.A., Jones A.S., Vaughan E.D., and Field J.K. Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck. Br J Cancer 72 1 (1995) 123-128
120. Sakata K. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma. J Oral Pathol Med 25 6 (1996) 302-307
121. Matsuda H., Konishi N., Hiasa Y., Hayashi I., Tsuzuki T., Tao M., et al. Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions. J Oral Pathol Med 25 5 (1996) 232-238
122. Saranath D., Chang S.E., Bhoite L.T., Panchal R.G., Kerr I.B., Mehta A.R., et al. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 63 4 (1991) 573-578
123. Das N., Majumder J., and DasGupta U.B. ras gene mutations in oral cancer in eastern India. Oral Oncol 36 1 (2000) 76-80
124. Sathyan K.M., Nalinakumari K.R., Abraham T., and Kannan S. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol (2006)
125. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 12 (1999) 1501-1512
126. Koontongkaew S., Chareonkitkajorn L., Chanvitan A., Leelakriangsak M., and Amornphimoltham P. Alterations of p53, pRb, cyclin D(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas. Oral Oncol 36 4 (2000) 334-339
127. Miyamoto R., Uzawa N., Nagaoka S., Hirata Y., and Amagasa T. Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas. Oral Oncol 39 6 (2003) 610-618
128. Rousseau A., Lim M.S., Lin Z., and Jordan R.C. Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias. Oral Oncol 37 3 (2001) 268-275
129. Myo K., Uzawa N., Miyamoto R., Sonoda I., Yuki Y., and Amagasa T. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity. Cancer 104 12 (2005) 2709-2716
130. Kushner J., Bradley G., Young B., and Jordan R.C. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J Oral Pathol Med 28 2 (1999) 77-81
131. Chen H.M., Kuo M.Y.P., Lin K.H., Lin C.Y., and Chiang C.P. Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan. Oral Oncol 39 5 (2003) 476-482
132. Hassan K.A., El-Naggar A.K., Soria J.C., Liu D., Hong W.K., and Mao L. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res 7 8 (2001) 2458-2462
133. Shang Z.J., Li Z.B., and Li J.R. VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies. Int J Oral Maxillofac Surg 35 6 (2006) 533-538
134. Li C., Shintani S., Terakado N., Klosek S.K., Ishikawa T., Nakashiro K., et al. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas. Int J Oral Maxillofac Surg 34 5 (2005) 559-565
135. Kishimoto K., Sasaki A., Yoshihama Y., Mese H., Tsukamoto G., and Matsumura T. Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma. Oral Oncol 39 4 (2003) 391-396
136. Tanigaki Y., Nagashima Y., Kitamura Y., Matsuda H., Mikami Y., and Tsukuda M. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma. Int J Mol Med 14 3 (2004) 389-395
137. Moriyama M., Kumagai S., Kawashiri S., Kojima K., Kakihara K., and Yamamoto E. Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 33 5 (1997) 369-374
138. Thomas G.T., Lewis M.P., and Speight P.M. Matrix metalloproteinases and oral cancer. Oral Oncol 35 3 (1999) 227-233
139. de Vicente J.C., Fresno M.F., Villalain L., Vega J.A., and Vallejo G.H. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 41 3 (2005) 283-293
140. Patel B.P., Shah P.M., Rawal U.M., Desai A.A., Shah S.V., Rawal R.M., et al. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 90 2 (2005) 81-88
141. Vicente de J.C., Fresno M.F., Villalain L., Vega J.A., and Arranz J.S.L. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma. Oral Oncol 41 6 (2005) 568-579
142. Pande P., Mathur M., Shukla N.K., and Ralhan R. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol 34 5 (1998) 396-403
143. Sartor M., Steingrimsdottir H., Elamin F., Gäken J., Warnakulasuriya S., Partridge M., et al. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Br J Cancer 80 1-2 (1999) 79-86
144. Reed A.L., Califano J., Cairns P., Westra W.H., Jones R.M., Koch W., et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56 16 (1996) 3630-3633
145. Wu C.L., Roz L., McKown S., Sloan P., Read A.P., Holland S., et al. DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes Cancer 25 1 (1999) 16-25
146. Shintani S., Nakahara Y., Mihara M., Ueyama Y., and Matsumura T. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol 37 6 (2001) 498-504
147. Weinberger P.M., Yu Z., Haffty B.G., Kowalski D., Harigopal M., Sasaki C., et al. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res 10 17 (2004) 5684-5691
148. Gorgoulis V.G., Vassiliou L.V.F., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 7035 (2005) 907-913
149. Bartkova J., Horejs Z., Koed K., Krmer A., Tort F., Zieger K., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 7035 (2005) 864-870
150. Ogden G.R., Kiddie R.A., Lunny D.P., and Lane D.P. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol 166 4 (1992) 389-394
151. de Vicente J.C., Gutiérrez L.M.J., Zapatero A.H., Forcelledo M.F.F., Hernández-Vallejo G., and Arranz J.S.L. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Head Neck 26 1 (2004) 22-30
152. Nees M., Homann N., Discher H., Andl T., Enders C., Herold-Mende C., et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res 53 18 (1993) 4189-4196
153. Ogden G.R., Chisholm D.M., Morris A.M., and Stevenson J.H. Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease. J Pathol 182 2 (1997) 180-184
154. Homann N., Nees M., Conradt C., Dietz A., Weidauer H., Maier H., et al. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin Cancer Res 7 2 (2001) 290-296
155. Xie X., Clausen O.P., Angelis P.D., and Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 86 6 (1999) 913-920
156. González-Moles M.A., Galindo P., Gutiérrez-Fernandez J., Sanchez-Fernandez E., Rodriguez-Archilla A., Ruiz-Avila I., et al. P53 protein expression in oral squamous cell carcinoma. survival analysis. Anticancer Res 21 4B (2001) 2889-2894
157. Yamazaki Y., Chiba I., Hirai A., Sugiura C., Notani ichi K., Kashiwazaki H., et al. Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma. Oral Oncol 39 2 (2003) 163-169
158. Shintani S., Mihara M., Nakahara Y., Terakado N., Yoshihama Y., Kiyota A., et al. Apoptosis and p53 are associated with effect of preoperative radiation in oral squamous cell carcinomas. Cancer Lett 154 1 (2000) 71-77
159. Alsner J., Sørensen S.B., and Overgaard J. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck. Radiother Oncol 59 2 (2001) 179-185
160. Jayasurya R., Francis G., Kannan S., Lekshminarayanan K., Nalinakumari K.R., Abraham T., et al. p53, p16 and cyclin D1: molecular determinants
161. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1288 2 (1996) F55-F78
162. Münger K., Scheffner M., Huibregtse J.M., and Howley P.M. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surv 12 (1992) 197-217
163. Syrjänen K., Syrjänen S., Lamberg M., Pyrhönen S., and Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12 6 (1983) 418-424
164. Gassenmaier A., and Hornstein O.P. Presence of human papillomavirus DNA in benign and precancerous oral leukoplakias and squamous cell carcinomas. Dermatologica 176 5 (1988) 224-233
165. Chatterjee R., Mukhopadhyay D., Chakraborty R.N., and Mitra R.B. Evaluation of argyrophilic nucleolar organizer regions (AgNORs) in oral carcinomas in relation to human papillomavirus infection and cytokinetics. J Oral Pathol Med 26 7 (1997) 310-314
166. Woods K.V., Shillitoe E.J., Spitz M.R., Schantz S.P., and Adler-Storthz K. Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J Oral Pathol Med 22 3 (1993) 101-108
167. Matzow T., Boysen M., Kalantari M., Johansson B., and Hagmar B. Low detection rate of HPV in oral and laryngeal carcinomas. Acta Oncol 37 1 (1998) 73-76
168. Elamin F., Steingrimsdottir H., Wanakulasuriya S., Johnson N., and Tavassoli M. Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in UK subjects: a novel method of detection. Oral Oncol 34 3 (1998) 191-197
169. Snijders P.J., Scholes A.G., Hart C.A., Jones A.S., Vaughan E.D., Woolgar J.A., et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 66 4 (1996) 464-469
170. Paz I.B., Cook N., Odom-Maryon T., Xie Y., and Wilczynski S.P. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79 3 (1997) 595-604
171. Koh J.Y., Cho N.P., Kong G., Lee J.D., and Yoon K. p53 mutations and human papillomavirus DNA in oral squamous cell carcinoma: correlation with apoptosis. Br J Cancer 78 3 (1998) 354-359
172. Riethdorf S., Friedrich R.E., Ostwald C., Barten M., Gogacz P., Gundlach K.K., et al. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. J Oral Pathol Med 26 7 (1997) 315-321
173. Miguel R.E., Villa L.L., Cordeiro A.C., Prado J.C., Sobrinho J.S., and Kowalski L.P. Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer. Am J Surg 176 5 (1998) 428-429
174. Cruz I.B., Snijders P.J., Steenbergen R.D., Meijer C.J., Snow G.B., Walboomers J.M., et al. Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Oncol 32B 1 (1996) 55-62
175. Bouda M., Gorgoulis V.G., Kastrinakis N.G., Giannoudis A., Tsoli E., Danassi-Afentaki D., et al. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 13 6 (2000) 644-653
176. Nielsen H., Norrild B., Vedtofte P., Praetorius F., Reibel J., and Holmstrup P. Human papillomavirus in oral premalignant lesions. Eur J Cancer B Oral Oncol 32B 4 (1996) 264-270
177. D'Costa J., Saranath D., Dedhia P., Sanghvi V., and Mehta A.R. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 34 5 (1998) 413-420
178. Fouret P., Martin F., Flahault A., and Saint-Guily J.L. Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol 4 2 (1995) 122-127
179. Sexton C.J., Proby C.M., Banks L., Stables J.N., Powell K., Navsaria H., et al. Characterization of factors involved in human papillomavirus type 16-mediated immortalization of oral keratinocytes. J Gen Virol 74 Pt 4 (1993) 755-761
180. Oda D., Bigler L., Lee P., and Blanton R. HPV immortalization of human oral epithelial cells: a model for carcinogenesis. Exp Cell Res 226 1 (1996) 164-169
181. Oda D., Bigler L., Mao E.J., and Disteche C.M. Chromosomal abnormalities in HPV-16-immortalized oral epithelial cells. Carcinogenesis 17 9 (1996) 2003-2008
182. Anand P., Foley P., Navsaria H.A., Sinicropi D., Williams-Chestnut R.E., and Leigh I.M. Nerve growth factor levels in cultured human skin cells: effect of gestation and viral transformation. Neurosci Lett 184 3 (1995) 157-160
183. Bryan D., Sexton C.J., Williams D., Leigh I.M., and McKay I.A. Oral keratinocytes immortalized with the early region of human papillomavirus type 16 show elevated expression of interleukin 6, which acts as an autocrine growth factor for the derived T103C cell line. Cell Growth Differ 6 10 (1995) 1245-1250
184. Li S.L., Kim M.S., Cherrick H.M., Doniger J., and Park N.H. Sequential combined tumorigenic effect of HPV-16 and chemical carcinogens. Carcinogenesis 13 11 (1992) 1981-1987
185. Park N.H., Gujuluva C.N., Baek J.H., Cherrick H.M., Shin K.H., and Min B.M. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene 10 11 (1995) 2145-2153
186. Itakura M., Mori S., Park N.H., and Bonavida B. Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis. Int J Oncol 16 3 (2000) 591-597
187. Mork J., Lie A.K., Glattre E., Hallmans G., Jellum E., Koskela P., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344 15 (2001) 1125-1131
188. Herrero R., Castellsagué X., Pawlita M., Lissowska J., Kee F., Balaram P., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95 23 (2003) 1772-1783
189. Ringström E., Peters E., Hasegawa M., Posner M., Liu M., and Kelsey K.T. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8 10 (2002) 3187-3192
190. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 9518 (2006) 1247-1255
191. Maeda H., Kubo K., Sugita Y., Miyamoto Y., Komatsu S., Takeuchi S., et al. DNA vaccine against hamster oral papillomavirus-associated oral cancer. J Int Med Res 33 6 (2005) 647-653
192. Sand L.P., Jalouli J., Larsson P.A., and Hirsch J.M. Prevalence of Epstein-Barr virus in oral squamous cell carcinoma, oral lichen planus, and normal oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 5 (2002) 586-592
193. González-Moles M., Gutiérrez J., Ruiz I., Fernández J.A., Rodriguez M., and Aneiros J. Epstein-Barr virus and oral squamous cell carcinoma in patients without HIV infection: viral detection by polymerase chain reaction. Microbios 96 383 (1998) 23-31
194. González-Moles M.A., Gutiérrez J., Rodriguez M.J., Ruiz-Avila I., and Rodriguez-Archilla A. Epstein-Barr virus latent membrane protein-1 (LMP-1) expression in oral squamous cell carcinoma. Laryngoscope 112 3 (2002) 482-487
195. Mao E.J., and Smith C.J. Detection of Epstein-Barr virus (EBV) DNA by the polymerase chain reaction (PCR) in oral smears from healthy individuals and patients with squamous cell carcinoma. J Oral Pathol Med 22 1 (1993) 12-17
196. Cruz I., Brule A.J.V.D., Brink A.A., Snijders P.J., Walboomers J.M., Waal I.V.D., et al. No direct role for Epstein-Barr virus in oral carcinogenesis: a study at the DNA, RNA and protein levels. Int J Cancer 86 3 (2000) 356-361
197. Iamaroon A., Khemaleelakul U., Pongsiriwet S., and Pintong J. Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma. J Oral Pathol Med 33 1 (2004) 30-36
198. Nagao Y., Sata M., Tanikawa K., Itoh K., and Kameyama T. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med 24 8 (1995) 354-360
199. Porter S.R., Lodi G., Chandler K., and Kumar N. Development of squamous cell carcinoma in hepatitis C virus-associated lichen planus. Oral Oncol 33 1 (1997) 58-59
200. Carrozzo M., Gandolfo S., Carbone M., Colombatto P., Broccoletti R., Garzino-Demo P., et al. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 25 10 (1996) 527-533
201. Muzio L.L., Mignogna M.D., Favia G., Procaccini M., Testa N.F., and Bucci E. The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol 34 4 (1998) 239-246
202. Nagao Y., Sata M., Noguchi S., Seno'o T., Kinoshita M., Kameyama T., et al. Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. J Oral Pathol Med 29 6 (2000) 259-266
203. Carrozzo M., Quadri R., Latorre P., Pentenero M., Paganin S., Bertolusso G., et al. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol 37 3 (2002) 364-369